ClinicalTrials.Veeva

Menu

Follow-up of Endovascular Aneurysm Treatment - The FEAT Trial

C

Clinical Research Office Imaging Division

Status

Completed

Conditions

Aortic Aneurysm, Abdominal

Treatments

Procedure: Computed Tomography Angiography
Procedure: Magnetic Resonance Angiography

Study type

Observational

Funder types

Other

Identifiers

NCT00281411
METC.2005.01.291E

Details and patient eligibility

About

After endovascular abdominal aortic aneurysm repair, life-long follow-up is needed to monitor the effectiveness of exclusion of the aneurysm sac from blood flow. For this reason, aneurysm diameter and the presence of endoleaks is evaluated with CT angiography yearly after Endovascular Aneurysm Repair (EVAR).

The aim of this study is to investigate the value of MRA examinations for the follow-up of these patients. The advantages of MRA with respect to CTA are no use of ionizing radiation, use of less nephrotoxic contrast agents.

Full description

The FEAT trial (Follow-up of Endovascular Aneurysm Treatment) is designed as a prospective, single-center, follow-up study. 100 Patients will be enrolled in this study. These patients will undergo additional MRA-examinations the day before EVAR, the day after EVAR, 6 months and 1 year after EVAR. These patients also participate in the conventional CTA follow-up scheme which comprises a pre- and post-operative CTA and a CTA yearly thereafter. Coagulation parameters in the blood will be measured before and 1 year after EVAR.

Enrollment

46 patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patient is planned for endovascular abdominal aortic aneurysm repair

Exclusion criteria

  • contraindication for MRI examination

    • claustrophobia
    • pacemaker
    • other non-MRI compatible implants

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems